A marriage of formal methods and LLMs seeks to harness the strengths of both.

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Spend your next few years studying at a center of intensive scholarship and boundless creativity and taking advantage of our multidimensional academic experience. Only here can you study a variety of ...

Finding the right book can make a big difference, especially when you’re just starting out or trying to get better. We’ve ...